178 related articles for article (PubMed ID: 35068280)
1. Current costs of dialysis modalities: A comprehensive analysis within the United Kingdom.
Roberts G; Holmes J; Williams G; Chess J; Hartfiel N; Charles JM; McLauglin L; Noyes J; Edwards RT
Perit Dial Int; 2022 Nov; 42(6):578-584. PubMed ID: 35068280
[TBL] [Abstract][Full Text] [Related]
2. The cost of renal dialysis in a UK setting--a multicentre study.
Baboolal K; McEwan P; Sondhi S; Spiewanowski P; Wechowski J; Wilson K
Nephrol Dial Transplant; 2008 Jun; 23(6):1982-9. PubMed ID: 18174268
[TBL] [Abstract][Full Text] [Related]
3. Cost analysis of dialysis modalities in Italy.
Tediosi F; Bertolini G; Parazzini F; Mecca G; Garattini L
Health Serv Manage Res; 2001 Feb; 14(1):9-17. PubMed ID: 11246787
[TBL] [Abstract][Full Text] [Related]
4. Healthcare systems and end-stage renal disease (ESRD) therapies--an international review: costs and reimbursement/funding of ESRD therapies.
De Vecchi AF; Dratwa M; Wiedemann ME
Nephrol Dial Transplant; 1999; 14 Suppl 6():31-41. PubMed ID: 10528710
[TBL] [Abstract][Full Text] [Related]
5. Cost of dialysis therapies in rural and remote Australia - a micro-costing analysis.
Gorham G; Howard K; Zhao Y; Ahmed AMS; Lawton PD; Sajiv C; Majoni SW; Wood P; Conlon T; Signal S; Robinson SL; Brown S; Cass A
BMC Nephrol; 2019 Jun; 20(1):231. PubMed ID: 31238898
[TBL] [Abstract][Full Text] [Related]
6. Comparison of cost-utility between automated peritoneal dialysis and continuous ambulatory peritoneal dialysis.
Cortés-Sanabria L; Paredes-Ceseña CA; Herrera-Llamas RM; Cruz-Bueno Y; Soto-Molina H; Pazarín L; Cortés M; Martínez-Ramírez HR
Arch Med Res; 2013 Nov; 44(8):655-61. PubMed ID: 24211750
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
Yang F; Lau T; Luo N
Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
[TBL] [Abstract][Full Text] [Related]
8. Healthcare costs of patients on different renal replacement modalities - Analysis of Dutch health insurance claims data.
Mohnen SM; van Oosten MJM; Los J; Leegte MJH; Jager KJ; Hemmelder MH; Logtenberg SJJ; Stel VS; Hakkaart-van Roijen L; de Wit GA
PLoS One; 2019; 14(8):e0220800. PubMed ID: 31415578
[TBL] [Abstract][Full Text] [Related]
9. Cost-Utility Analysis of Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis for Thai Patients With End-Stage Renal Disease.
Thaweethamcharoen T; Sritippayawan S; Noparatayaporn P; Aiyasanon N
Value Health Reg Issues; 2020 May; 21():181-187. PubMed ID: 32044691
[TBL] [Abstract][Full Text] [Related]
10. Estimating the cost of home dialysis in Tunisia: Application of the Activity-based costing methodology.
Chabouh S; Hammami S; El Amraoui A; Bouchriha H; Guedri Y; Achour A; Fessi H
Tunis Med; 2022 juin; 100(6):428-437. PubMed ID: 36206061
[TBL] [Abstract][Full Text] [Related]
11. Economic costs of automated and continuous ambulatory peritoneal dialysis in Taiwan: a combined survey and retrospective cohort analysis.
Tang CH; Wu YT; Huang SY; Chen HH; Wu MJ; Hsu BG; Tsai JC; Chen TH; Sue YM
BMJ Open; 2017 Mar; 7(3):e015067. PubMed ID: 28325860
[TBL] [Abstract][Full Text] [Related]
12. Barriers to successful implementation of care in home haemodialysis (BASIC-HHD):1. Study design, methods and rationale.
Jayanti A; Wearden AJ; Morris J; Brenchley P; Abma I; Bayer S; Barlow J; Mitra S
BMC Nephrol; 2013 Sep; 14():197. PubMed ID: 24044499
[TBL] [Abstract][Full Text] [Related]
13. Direct and indirect costs of end-stage renal disease patients in the first and second years after initiation of nocturnal home haemodialysis, hospital haemodialysis and peritoneal dialysis.
Wong CKH; Chen J; Fung SKS; Mok MMY; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
Nephrol Dial Transplant; 2019 Sep; 34(9):1565-1576. PubMed ID: 30668781
[TBL] [Abstract][Full Text] [Related]
14. Lifetime cost-effectiveness analysis of first-line dialysis modalities for patients with end-stage renal disease under peritoneal dialysis first policy.
Wong CKH; Chen J; Fung SKS; Mok M; Cheng YL; Kong I; Lo WK; Lui SL; Chan TM; Lam CLK
BMC Nephrol; 2020 Feb; 21(1):42. PubMed ID: 32019528
[TBL] [Abstract][Full Text] [Related]
15. Cost Effectiveness of Dialysis Modalities: A Systematic Review of Economic Evaluations.
Howell M; Walker RC; Howard K
Appl Health Econ Health Policy; 2019 Jun; 17(3):315-330. PubMed ID: 30714086
[TBL] [Abstract][Full Text] [Related]
16. Economic evaluation of centre haemodialysis and continuous ambulatory peritoneal dialysis in Ministry of Health hospitals, Malaysia.
Hooi LS; Lim TO; Goh A; Wong HS; Tan CC; Ahmad G; Morad Z
Nephrology (Carlton); 2005 Feb; 10(1):25-32. PubMed ID: 15705178
[TBL] [Abstract][Full Text] [Related]
17. Economic evaluation of three dialysis methods in patients with end-stage renal disease in China.
Hong Z; Zhuang Y; Lu J; Ye J; Sun H; Gao L; Xiong Y
Int Urol Nephrol; 2023 May; 55(5):1247-1254. PubMed ID: 36376531
[TBL] [Abstract][Full Text] [Related]
18. Costs of home assistance for peritoneal dialysis: results of a European survey.
Dratwa M
Kidney Int Suppl; 2008 Apr; (108):S72-5. PubMed ID: 18379552
[TBL] [Abstract][Full Text] [Related]
19. The financial impact of increasing home-based high dose haemodialysis and peritoneal dialysis.
Liu FX; Treharne C; Culleton B; Crowe L; Arici M
BMC Nephrol; 2014 Oct; 15():161. PubMed ID: 25278356
[TBL] [Abstract][Full Text] [Related]
20. Comparison of direct medical costs between automated and continuous ambulatory peritoneal dialysis.
Cortés-Sanabria L; Rodríguez-Arreola BE; Ortiz-Juárez VR; Soto-Molina H; Pazarín-Villaseñor L; Martínez-Ramírez HR; Cueto-Manzano AM
Perit Dial Int; 2013; 33(6):679-86. PubMed ID: 23547280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
